Literature DB >> 1402029

Immune activation during measles: beta 2-microglobulin in plasma and cerebrospinal fluid in complicated and uncomplicated disease.

D E Griffin1, B J Ward, E Juaregui, R T Johnson, A Vaisberg.   

Abstract

Beta 2-microglobulin (beta 2m) is a small protein that forms the light chain of the class I major histocompatibility molecule and is also present in soluble form in serum and cerebrospinal fluid (CSF). Measles is associated with immune activation and evidence of immunologic abnormalities that persist for several weeks. To assess further the immunologic changes occurring during measles, beta 2m was measured in plasma and CSF. beta 2m became elevated during measles before the onset of the rash and was highest during the rash. Elevations persisted for several weeks and correlated well with levels of soluble interleukin-2 receptor and neopterin and less well with soluble CD8. CSF beta 2m was elevated in postmeasles encephalomyelitis. Plasma levels of beta 2m did not correlate with spontaneous proliferation of peripheral blood mononuclear cells (PBMC) or with in vitro production of beta 2m by cultured PBMC. The data suggest that increases in beta 2m in measles correlate better with cytokine production than with cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402029     DOI: 10.1093/infdis/166.5.1170

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  Immune containment and consequences of measles virus infection in healthy and immunocompromised individuals.

Authors:  Sallie R Permar; Diane E Griffin; Norman L Letvin
Journal:  Clin Vaccine Immunol       Date:  2006-04

Review 2.  Emerging diseases: measles.

Authors:  Martin O Ota; William J Moss; Diane E Griffin
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

3.  Restriction analysis of otosclerosis-associated CD46 splicing variants.

Authors:  Péter Csomor; Anita Szalmás; József Kónya; István Sziklai; Tamás Karosi
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-14       Impact factor: 2.503

Review 4.  Measles virus-induced suppression of immune responses.

Authors:  Diane E Griffin
Journal:  Immunol Rev       Date:  2010-07       Impact factor: 12.988

5.  Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles.

Authors:  Judith J Ryon; William J Moss; Mwaka Monze; Diane E Griffin
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

6.  Gene expression changes in peripheral blood mononuclear cells during measles virus infection.

Authors:  Michael J Zilliox; William J Moss; Diane E Griffin
Journal:  Clin Vaccine Immunol       Date:  2007-05-30

7.  Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys.

Authors:  Sallie R Permar; Sherry A Klumpp; Keith G Mansfield; Woong-Ki Kim; Darci A Gorgone; Michelle A Lifton; Kenneth C Williams; Jörn E Schmitz; Keith A Reimann; Michael K Axthelm; Fernando P Polack; Diane E Griffin; Norman L Letvin
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 8.  Neopterin in Diagnosis and Monitoring of Infectious Diseases.

Authors:  Michael Eisenhut
Journal:  J Biomark       Date:  2013-12-08

9.  In Vitro Measles Virus Infection of Human Lymphocyte Subsets Demonstrates High Susceptibility and Permissiveness of both Naive and Memory B Cells.

Authors:  Brigitta M Laksono; Christina Grosserichter-Wagener; Rory D de Vries; Simone A G Langeveld; Maarten D Brem; Jacques J M van Dongen; Peter D Katsikis; Marion P G Koopmans; Menno C van Zelm; Rik L de Swart
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

Review 10.  The Immune Response in Measles: Virus Control, Clearance and Protective Immunity.

Authors:  Diane E Griffin
Journal:  Viruses       Date:  2016-10-12       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.